Cargando…
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone
BACKGROUND: The long-term safety of growth hormone treatment is uncertain. Raised risks of death and certain cancers have been reported inconsistently, based on limited data or short-term follow-up by pharmaceutical companies. Patients and Methods: The SAGhE (Safety and Appropriateness of Growth Hor...
Autores principales: | Swerdlow, Anthony J, Cooke, Rosi, Albertsson-Wikland, Kersti, Borgström, Birgi, Butler, Gar, Cianfarani, Stefan, Clayton, Pete, Coste, Joë, Deodati, Annalis, Ecosse, Emmanue, Gausche, Rut, Giacomozzi, Claudi, Kiess, Wielan, Hokken-Koelega, Anita C.S, Kuehni, Claudia E, Landier, Fabienn, Maes, Mar, Mullis, Primus-E, Pfaffle, Rolan, Sävendahl, Lar, Sommer, Gri, Thomas, Murie, Tollerfield, Sall, Zandwijken, Gladys R.J, Carel, Jean-Claud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611066/ https://www.ncbi.nlm.nih.gov/pubmed/26227295 http://dx.doi.org/10.1159/000435856 |
Ejemplares similares
-
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort
por: Swerdlow, Anthony J, et al.
Publicado: (2018) -
How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013) -
The Rationale for Growth Hormone Therapy in Children with Short Stature
por: Deodati, Annalisa, et al.
Publicado: (2017) -
Epigenetics and In Utero Acquired Predisposition to Metabolic Disease
por: Deodati, Annalisa, et al.
Publicado: (2020) -
Perspectives of the European Society of Endocrinology (ESE) and the European Society of Paediatric Endocrinology (ESPE) on rare endocrine disease
por: Reincke, Martin, et al.
Publicado: (2021)